1-3 of 3
Elaina V. Preston, PA-C,MPH
Close
Sort by
Journal Articles

Impact of Pre-Transplant Rituximab on Efficacy of Revaccination of Lymphoma Patients after Autologous Hematopoietic Stem Cell Transplantation

Elaina V. Preston, PA-C,MPH, Meighan A. Palazzo, BSN MSN NP-C, Kenneth Seier, MS, Sean M Devlin, PhD, Sergio Giralt, MD, Michael Scordo, MD, Parastoo B. Dahi, MD, Matthew J Matasar, Craig H. Moskowitz, MD, Craig S. Sauter, MD, Gunjan L. Shah, MD, Miguel-Angel Perales, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4592.
https://doi.org/10.1182/blood-2018-99-112509
Published: 2018
Journal Articles

Dysgeusia Is Associated with Higher Melphalan Pharmacokinetic Levels and Results in Poorer Caloric Intake and Worse Symptom Burden after Autologous Stem Cell Transplantation for Multiple Myeloma

Michael Scordo, MD, Gunjan L. Shah, MD, Elaina V. Preston, PA-C, MPH, Natasia Rodriguez, BSN, RN, Andrew Lin, PharmD, BCOP, Molly Maloy, MS, Brooke Mastrogiacomo, BS, Dean Carlow, MD PhD, Ryan Schofield, MS, Andrea Knezevic, MS, Sean M Devlin, PhD, Heather J. Landau, MD, David J. Chung, MD PhD, Jonathan U. Peled, MD PhD, Marissa L. Buchan, MS, Sergio Giralt, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2136.
https://doi.org/10.1182/blood-2018-99-114715
Published: 2018
Journal Articles

Feasibility, Tolerability, and Patient-Reported Outcomes with Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan) for Multiple Myeloma and AL Amyloidosis Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)

Gunjan L. Shah, MD, Andrew Lin, PharmD, Ryan Schofield, MS, Caitlin Sarubbi, AB, Elaina V. Preston, PA-C,MPH, Sean M. Devlin, PhD, Valkal Bhatt, PharmD, Stephen J. Harnicar, PharmD, Elizabeth Hoover, BS, David J. Chung, MDPhD, Parastoo B. Dahi, MD, Guenther Koehne, MDPhD, Roni Tamari, MD, Dean Carlow, MDPhD, Sergio A. Giralt, MD, Heather Landau, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2023.
https://doi.org/10.1182/blood.V130.Suppl_1.2023.2023
Published: 2017